Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

European heart journal - 7 Oct 2015

González-López Esther, Gallego-Delgado Maria, Guzzo-Merello Gonzalo, de Haro-Del Moral F Javier, Cobo-Marcos Marta, Robles Carolina, Bornstein Belén, Salas Clara, Lara-Pezzi Enrique, Alonso-Pulpon Luis, Garcia-Pavia Pablo

Abstract excerpt

AIMS: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous clinical syndrome with multiple underlying causes. Wild-type transthyretin (TTR) amyloidosis (ATTRwt) is an underdiagnosed cause of HFpEF that might benefit from new specific treatments. ATTRwt can be diagnosed non-invasively by (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid ((99m)Tc-DPD) scintigraphy. We sought to determine the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies, Familial
Share to Diphosphonates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Echocardiography

Share to Hypertrophy, Left Ventricular

Share to Length of Stay

Share to Radionuclide Imaging

Share to Radiopharmaceuticals

Share to Stroke Volume

Source

Identifiers

PMID: 26224076
DOI: 10.1093/eurheartj/ehv338

Genes

TTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.PMID 26224076Read ↗

Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fraction.Semantic proximity Read ↗

Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.Semantic proximity Read ↗

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis.Semantic proximity Read ↗

Not So Rare After All: Rethinking Hereditary Transthyretin AmyloidosisSemantic proximity Read ↗

ATTR Epidemiology, Genetics, and Prognostic FactorsSemantic proximity Read ↗

Transthyretin Amyloid Cardiomyopathy–2025 Update: Current Diagnostic Approaches and Emerging Therapeutic OptionsSemantic proximity Read ↗

Diagnostic Pitfall and Clinical Characteristics of Variant Versus Wild-Type Transthyretin Amyloid Cardiomyopathy in Asian Population: The Korean Nationwide Cohort Study.Semantic proximity Read ↗

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathySemantic proximity Read ↗

Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.Semantic proximity Read ↗

Amyloid Cardiomyopathy.Semantic proximity Read ↗

Transthyretin cardiac amyloidoses in older North Americans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.